Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival
- 7 February 2015
- journal article
- research article
- Published by Elsevier BV in European Journal of Radiology
- Vol. 84 (5), 998-1004
- https://doi.org/10.1016/j.ejrad.2015.01.021
Abstract
No abstract availableKeywords
Funding Information
- NCI (1K23CA157631)
- National Institutes of Health (1RO1CA114465-07, 5R21CA11627-02)
- National Cancer Institute Specialized Program of Research Excellence in Lung Cancer (2P50CA090578-10)
- Genentech Inc
- Doris and William Krupp Research Fund in Thoracic Oncology
- Gallup Fund in Thoracic Oncology
- American Society of Clinical Oncology Translational Research Professorship
This publication has 27 references indexed in Scilit:
- Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinomaLung Cancer, 2013
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Idiopathic pulmonary fibrosisThe Lancet, 2011
- Pack‐years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancerCancer, 2009
- The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung CancerChest, 2004
- Smoking and Lung Cancer SurvivalChest, 2004
- Inflammation and cancerNature, 2002
- Association of Malignancy With Diseases Causing Interstitial Pulmonary ChangesChest, 2002
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2002